These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 9707161)

  • 21. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder.
    Yeragani VK; Pohl R; Jampala VC; Balon R; Ramesh C; Srinivasan K
    Depress Anxiety; 2000; 11(3):126-30. PubMed ID: 10875054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of current treatment in panic disorder.
    den Boer JA; Slaap BR
    Int Clin Psychopharmacol; 1998 Apr; 13 Suppl 4():S25-30. PubMed ID: 9690962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzodiazepines versus antidepressants for panic disorder.
    Kline NA
    Am J Psychiatry; 2004 Jul; 161(7):1312. PubMed ID: 15229080
    [No Abstract]   [Full Text] [Related]  

  • 25. Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
    Mochcovitch MD; Nardi AE
    Expert Rev Neurother; 2010 Aug; 10(8):1285-93. PubMed ID: 20662754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What treatments do patients with panic disorder and agoraphobia get?
    Bandelow B; Sievert K; Röthemeyer M; Hajak G; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):165-71. PubMed ID: 7669824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of SSRIs in panic disorder.
    Sheehan DV; Harnett-Sheehan K
    J Clin Psychiatry; 1996; 57 Suppl 10():51-8; discussion 59-60. PubMed ID: 8917132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
    Gunasekara NS; Noble S; Benfield P
    Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WCA recommendations for the long-term treatment of panic disorder.
    Pollack MH; Allgulander C; Bandelow B; Cassano GB; Greist JH; Hollander E; Nutt DJ; Okasha A; Swinson RP;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):17-30. PubMed ID: 14767395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Panic disorder.
    Kumar S; Oakley-Browne M
    Clin Evid; 2002 Dec; (8):1003-9. PubMed ID: 12603925
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Panic disorder.
    Kumar S; Oakley-Browne M
    Clin Evid; 2003 Dec; (10):1188-95. PubMed ID: 15555142
    [No Abstract]   [Full Text] [Related]  

  • 34. Panic disorder.
    Kumar S; Oakley-Browne M
    Clin Evid; 2004 Jun; (11):1335-42. PubMed ID: 15652062
    [No Abstract]   [Full Text] [Related]  

  • 35. The pharmacotherapy of panic disorder.
    Rosenbaum JF; Pollock RA; Jordan SK; Pollack MH
    Bull Menninger Clin; 1996; 60(2 Suppl A):A54-75. PubMed ID: 8857427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic treatment of panic disorder.
    Stein M; Steckler T; Lightfoot JD; Hay E; Goddard AW
    Curr Top Behav Neurosci; 2010; 2():469-85. PubMed ID: 21309122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressants in panic disorder.
    Wade AG
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S13-7. PubMed ID: 10471168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term management of panic disorder.
    Doyle A; Pollack MH
    J Clin Psychiatry; 2004; 65 Suppl 5():24-8. PubMed ID: 15078115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citalopram: new indication. No advantage.
    Prescrire Int; 1999 Feb; 8(39):18-9. PubMed ID: 10557570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benzodiazepines versus placebo for panic disorder in adults.
    Breilmann J; Girlanda F; Guaiana G; Barbui C; Cipriani A; Castellazzi M; Bighelli I; Davies SJ; Furukawa TA; Koesters M
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010677. PubMed ID: 30921478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.